Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Ophthalmology

How Often Do ADOA Patients Need OCT & Visual Field Tests?

At a Glance

For stable adults with Autosomal Dominant Optic Atrophy (ADOA), eye specialists generally recommend getting an OCT scan and visual field test once a year. More frequent testing may be needed for children, newly diagnosed patients, or those experiencing rapid vision changes.

For most stable adults with Autosomal Dominant Optic Atrophy (ADOA), the general clinical consensus is to get an Optical Coherence Tomography (OCT) scan and a visual field test once a year. These annual check-ups allow your eye care team to closely monitor any structural changes in your optic nerve and retina, as well as track how well your eyes are functioning in everyday life [1]. While annual testing is the standard for stable patients, your doctor may recommend more frequent visits depending on your age, recent symptom changes, or how recently you were diagnosed.

Getting your eyes checked when you have a progressive condition like ADOA can be emotionally taxing. It is completely normal to feel anxiety before an appointment. However, routine monitoring is not just about documenting changes—it is an active step in preserving your quality of life and ensuring you have the right tools, accommodations, and support for your current level of vision [1].

What to Expect on Test Day

Because your care team needs to perform both structural imaging and functional testing, you should plan for these appointments to take 1 to 2 hours. Your doctor will likely need to dilate your eyes to get a clear view of your optic nerve and retina. Since dilation causes light sensitivity and blurry vision that can last for several hours, it is highly recommended to bring sunglasses and have someone drive you home afterward.

Structural Imaging: Looking at the Eye

Optical Coherence Tomography (OCT)

An OCT scan is a non-invasive imaging test that uses light waves to take cross-section pictures of your retina. The test is completely painless, takes only a few minutes, and nothing will touch your eye. For ADOA patients, this test is critical because it measures the thickness of specific cell layers impacted by the condition:

  • Retinal Nerve Fiber Layer (RNFL): This is the layer of nerve fibers that carry visual information from the eye to the brain. In ADOA, structural degeneration often appears as thinning of the RNFL [2][3].
  • Ganglion Cell Complex (GCC): The GCC consists of the cell bodies that eventually form the optic nerve. Recent research highlights GCC thickness as a highly reliable and significant biomarker for tracking disease progression in ADOA [4].

Even if your vision feels stable, regular OCT scans are essential because structural thinning (like in the RNFL) can sometimes be detected before you notice any major changes in your day-to-day eyesight [5].

Functional Testing: Measuring What You See

While OCT looks at the physical structure of your eye, functional testing measures how your eyes perform in real life.

  • Visual Acuity and Color Vision: Because ADOA classically causes slowly progressive visual acuity loss and color vision defects (often making it hard to distinguish blue and yellow), routine checks of your sharpness of vision and color perception are fundamental components of tracking your condition [1].
  • Visual Field Testing (Perimetry): Standard Automated Perimetry (SAP) maps out your central and peripheral (side) vision by asking you to press a button when you see flashes of light. It provides clinically relevant information about how much retinal involvement you have and helps identify areas of reduced vision (scotomas) [6]. Tracking these parameters directly correlates with the physical changes seen on your OCT scans [6][7].

Why Monitor if There Is No Cure?

It is natural to wonder why you need detailed monitoring for a condition that cannot currently be reversed. These tests are essential for two main reasons:

  1. Practical Support: Identifying exactly how and where your vision is changing allows your team to connect you with the right low-vision aids, school or workplace accommodations, and mobility training.
  2. Future Readiness: Researchers are actively investigating emerging therapeutic approaches for hereditary optic neuropathies like ADOA [8][9]. Having a well-documented, long-term record of your baseline and progression (particularly your RNFL and GCC thickness) may be crucial for determining your eligibility for future clinical trials or treatments.

When Might I Need More Frequent Testing?

While annual exams are standard for stable adults, your specialist may want to see you more often in the following situations:

  • During Childhood: Children’s visual systems are still developing. Because ADOA typically presents in childhood, pediatric patients often need closer monitoring to track the progression of vision loss and manage early educational interventions [10].
  • Right After Diagnosis: If you have just been diagnosed with ADOA, your doctor will likely schedule follow-up appointments closer together (for example, every 3 to 6 months) to establish a firm baseline and determine your initial rate of change.
  • If You Notice Rapid Changes: If you experience a sudden or rapid decline in your visual acuity, color vision, or central vision, do not wait for your scheduled annual exam. Contact your eye doctor immediately for updated testing.

Common questions in this guide

How often should I get my eyes checked for ADOA?
Most stable adults with ADOA should undergo an OCT scan and visual field testing once a year. Your eye specialist may recommend more frequent visits if you were recently diagnosed or have noticed a sudden change in your symptoms.
What does an OCT scan measure for ADOA?
An OCT scan is a painless, non-invasive imaging test that measures the thickness of specific cell layers in your retina, such as the Retinal Nerve Fiber Layer (RNFL) and Ganglion Cell Complex (GCC). Thinning in these specific areas is a key indicator of ADOA progression.
Why do I need visual field testing if I already had an OCT scan?
While an OCT scan looks at the physical structure of your eye, visual field testing measures how well your eyes actually perform in daily life. It maps out your central and side vision to identify any blind spots or areas of reduced vision.
Why is monitoring necessary if ADOA currently has no cure?
Regular testing helps your care team track your exact vision changes to connect you with necessary low-vision aids, mobility training, and workplace accommodations. Furthermore, having a documented history of your eye health may be crucial for determining your eligibility for future clinical trials.
Why do children with ADOA need more frequent eye exams?
Children's visual systems are still developing, and ADOA typically presents during childhood. Pediatric patients often require closer monitoring than once a year to track vision loss progression and help manage early educational interventions.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my baseline RNFL and GCC thickness, and how much have they changed since my last visit?
  2. 2.Are the structural changes on my OCT scan aligning with the changes you are seeing in my visual field and visual acuity tests?
  3. 3.Given my current test results, are there new low-vision aids, filters, or accommodations I should be considering for my daily life?
  4. 4.Based on my current rate of progression, should I continue scheduling my follow-ups annually, or do you recommend I come back sooner?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Correlation between quality of vision and clinical and structural parameters in patients with Autosomal Dominant Optic Atrophy.

    Camós-Carreras A, Figueras-Roca M, Albà-Arbalat S, et al.

    Eye (London, England) 2025; (39(9)):1837-1842 doi:10.1038/s41433-025-03762-w.

    PMID: 40140688
  2. 2

    Thickness mapping of individual retinal layers and sectors by Spectralis SD-OCT in Autosomal Dominant Optic Atrophy.

    Corajevic N, Larsen M, Rönnbäck C

    Acta ophthalmologica 2018; (96(3)):251-256 doi:10.1111/aos.13588.

    PMID: 29091347
  3. 3

    Genotype-phenotype heterogeneity of ganglion cell and inner plexiform layer deficit in autosomal-dominant optic atrophy.

    Rönnbäck C, Nissen C, Almind GJ, et al.

    Acta ophthalmologica 2015; (93(8)):762-6 doi:10.1111/aos.12835.

    PMID: 26385429
  4. 4

    Clinical and Structural Parameters in Autosomal Dominant Optic Atrophy Patients: A Cross-Sectional Study Using Optical Coherence Tomography.

    Camós-Carreras A, Figueras-Roca M, Albà-Arbalat S, et al.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2024; (45(3)):273-277 doi:10.1097/WNO.0000000000002294.

    PMID: 39805076
  5. 5

    Case of autosomal dominant optic atrophy with relatively good visual function.

    Tachibana M, Hayashi T, Igawa Y, et al.

    BMC ophthalmology 2025; (25(1)):443 doi:10.1186/s12886-025-04276-5.

    PMID: 40751186
  6. 6

    Short Wavelength Automated Perimetry, Standard Automated Perimetry, and Optical Coherence Tomography in Dominant Optic Atrophy.

    Lombardo M, Cusumano A, Mancino R, et al.

    Journal of clinical medicine 2024; (13(7)) doi:10.3390/jcm13071971.

    PMID: 38610740
  7. 7

    Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry.

    Cesareo M, Ciuffoletti E, Martucci A, et al.

    PloS one 2017; (12(3)):e0174560 doi:10.1371/journal.pone.0174560.

    PMID: 28358911
  8. 8

    Solutions to a Radical Problem: Overview of Current and Future Treatment Strategies in Leber's Hereditary Opic Neuropathy.

    Spiegel SJ, Sadun AA

    International journal of molecular sciences 2022; (23(21)) doi:10.3390/ijms232113205.

    PMID: 36361994
  9. 9

    Mitochondrial Genetics and Optic Neuropathy.

    Wiggs JL

    Annual review of vision science 2015; (1()):97-124 doi:10.1146/annurev-vision-082114-035651.

    PMID: 28532377
  10. 10

    Visual Function and Inner Retinal Structure in Relation to Birth Factors in Autosomal Dominant Optic Atrophy.

    Eckmann-Hansen C, Bek T, Sander B, Larsen M

    Investigative ophthalmology & visual science 2023; (64(10)):32 doi:10.1167/iovs.64.10.32.

    PMID: 37498569

This page provides educational information about ADOA monitoring and eye testing. It does not replace professional medical advice, so always consult your eye care specialist regarding your specific testing schedule.

Get notified when new evidence is published on Autosomal dominant optic atrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.